| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2765 | |||||||||||||||||||||||
| Submitter : | Mr. Matthew Farinholt | Date & Time: | 12/08/2006 09:12:20 | |||||||||||||||||||||
| Organization : | Mr. Matthew Farinholt | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am absolutely opposed to the use of tissue from any aborted human fetus for the production of stem cell lines. There are ethical alternatives to the use of aborted fetal material. I request that the government ensure that ethical methods are used in the development of vaccines. | ||||||||||||||||||||||||